The role of epidemiological evidence in the care for individual patients;De rol van epidemiologisch bewijs in de zorg voor individuele patiënten

Nederlands Tijdschrift voor Geneeskunde

Volumn 154, Issue 19, 2010, Pages 892-896

  Smulders, Yvo M ^a   Levi, Marcel ^b   Stehouwer, Coen D A ^c   Kramer, Mark H H ^a   Thijs, Abel ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIVITAMIN K; PLACEBO; SPIRONOLACTONE;

BLEEDING; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFICACY; ECONOMIC DEVELOPMENT; EPIDEMIOLOGICAL DATA; ETHNICITY; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH INSURANCE; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPOTHESIS; INDIVIDUALITY; INTEGRATED HEALTH CARE SYSTEM; META ANALYSIS; NOTE; PATHOPHYSIOLOGY; PATIENT CARE; PEER REVIEW; PUBLICATION; SOCIOECONOMICS; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TERTIARY HEALTH CARE; VALIDITY;

EID: 77952651509     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (20)

1. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312:71-72.
2. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr. Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines. JAMA. 2009;301:831-841
3. Sox HC, Greenfield S. Comparative Effectiveness Research: A Report From the Institute of Medicine. Ann Intenal Med. 2009;151:203-205
4. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens. 2005;23:2101-2107 (Pubitemid 41830407)
5. Newman-Toker DE, Pronovost PJ. Diagnostic Errors - The Next Frontier for Patient Safety. JAMA. 2009;301:1060-1062
6. Garfunkel JM, Ulshen MH, Hamrick HJ, Lawson EE. Effect of institutional prestige on reviewers' recommendations and editorial decisions. JAMA. 1994;272:137-138
7. Link AM. US and Non-US Submissions: An Analysis of Reviewer Bias. JAMA. 1998;280:246-247
8. Song F, Parekh-Bhurke S, Hooper L, et al. Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res Methodol. 2009;9:79.
9. Vermeulen M. Dwalingen in de methodologie. XXXVI. Van 'likelihood'-ratio's en de regel van Bayes. Ned Tijdschr Geneeskd. 2001;145:2421-2424
10. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet. 2008;372:2152-2161
11. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.
12. Moonesinghe R, Khoury MJ, Janssens AC. Most published research findings are false-but a little replication goes a long way. PLoS Med. 2007;4:e28. (Pubitemid 46354425)
13. Greenberg SA. How citation distortions create unfounded authority: analysis of a citation network. BMJ. 2009;339:b2680.
14. Rothwell PM. External validity of randomised controlled trials: "To whom do the results of this trial apply? Lancet. 2005;365:82-93.
15. Van Spall HGC, Toren A, Kiss A, Fowler RA. Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals: A Systematic Sampling Review. JAMA. 2007;297:1233-1240
16. Levi M, Hovingh GK, Cannegieter SC, Vermeulen M, Buller HR, Rosendaal FR. Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood. 2008;111:4471-4476
17. Pitt B, Zannad F, Remme WJ, et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure. N Engl J Med. 1999;341:709-717 (Pubitemid 29407370)
18. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351:543-551
19. Stehouwer CDA. De oorzaak ontmaskerd? Oratie. VU Boekhandel, 2001.
20. Smulders YM. Vrijheid om af te wijken. Med Contact 2008;43:1763-1766